EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PTCT: Ptc Therapeutics

05 Nov 25 08:05
LAST:

70.50

CHANGE:
 2.78		OPEN:
71.50		HIGH:
72.25		ASK:
15.45		VOLUME:
7.0K
CHG(%):
4.11		PREV:
67.72		LOW:
70.50		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 2571.5072.2570.5070.507.0K
04 Nov 2566.8868.8066.2167.721.34M
03 Nov 2567.8669.2466.1067.931.02M
31 Oct 2567.8669.2867.5768.31816.0K
30 Oct 2567.3669.8867.1468.11855.7K
29 Oct 2567.8668.1466.4467.35545.9K
28 Oct 2566.8668.1766.0067.49765.0K
27 Oct 2566.8069.2266.6867.08856.2K
24 Oct 2566.7267.7865.8166.40545.1K
23 Oct 2566.0967.5166.0966.80503.7K

COMPANY PROFILE

Name:Ptc Therapeutics
About:PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and inflammation and ferroptosis platforms, including vatiquinone to treat Friedreich's ataxia. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. It markets Upstaza, a gene therapy with the brand name Kebilidi in the United States. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in Warren, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:500 Warren Corporate Center Drive, Warren, NJ, United States, 07059
Website:https://www.ptcbio.com
CUSIP:69366J200
CIK:0001070081
ISIN:US69366J2006
FIGI:BBG000QT15P7
LEI:549300UJLWOIWFDGB318

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:9.69 
Forward P/E:-18.56 
PEG Ratio:-0.27 
Price to Sales:3.07 
Price to Book:-25.70 
Profit Margin:0.36 
Operating Margin:-0.19 
Return on Assets:0.24 
Return on Equity:0.33 
EPS Ratio:7.05 
Revenue:1.765B 
EBITDA:35.36M 
Shares:79.44M 
Market Cap:5.60B 

TECHNICAL INDICATORS

MA5:68.512.9%
MA10:67.774.0%
MA20:67.274.8%
MA50:62.3913.0%
MA100:55.6126.8%
MA200:52.3634.6%
STO9:70.09
STO14:72.22
RSI14:66.20 
MTM14:4.55
ROC14:0.07 
ATR:2.37 
Week High:72.252.5%
Week Low:66.106.7%
Month High:72.252.5%
Month Low:62.3234.6%
Year High:72.252.5%
Year Low:35.9596.1%
Volatility:28.36